About
Lung Disease Treatment
Areas of Focus
Categories
Biotech
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
4
As Collaborator
4
Total Enrollment
151,040
By Phase
NA: 5PHASE2: 1
By Status
ACTIVE_NOT_RECRUITING: 3RECRUITING: 2NOT_YET_RECRUITING: 1ENROLLING_BY_INVITATION: 1COMPLETED: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
Today
Hover over trial bars to see details
Recent Trials
NCT07126379Collaborator
The Family Foundations Trial
NANot yet recruiting
472 participants
Started: Oct 1, 2025 · Completed: Aug 1, 2027
NCT06891755Lead Sponsor
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
NARecruiting
250 participants
Started: Jul 15, 2025 · Completed: Dec 31, 2029
NCT06940193Lead Sponsor
A Self-test Home-use Blood Phenylalanine Monitoring System Under the Brand Name Egoo Phe System Has Been Developed for Measurement of Phenylalanine (Phe) in Individuals Diagnosed With Phenylketonuria (PKU): The Study Purpose is to Evaluate Accuracy and Usability
N/AEnrolling by invitation
20 participants
Started: Apr 15, 2025 · Completed: Oct 31, 2025
NCT05949645Lead Sponsor
Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema
NAActive, not recruiting
30 participants
Started: Aug 15, 2023 · Completed: Jun 1, 2026
NCT05854550Lead Sponsor
First in Human Study to Assess an Implant to Treat Severe Emphysema
NAActive, not recruiting
48 participants
Started: May 5, 2023 · Completed: Jun 1, 2026
Funding History (1)
D
Aug 19, 2025
Locations (1)
Headquarters
Menlo Park, CA, United States
Map
Loading map...